Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Stockholder-Equity" stands at 44.75 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2024.
As of the end of Novartis AG's third quarter, the item "Total Stockholder Equity" stands at 44.75 Billion USD. This represents an increase of 6.42 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.02 percent compared to the value the year prior.
The 1 year change in percent is 3.02.
The 3 year change in percent is -26.51.
The 5 year change in percent is -17.97.
The 10 year change in percent is -41.72.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Stockholder Equity | 280,205,508,085.11 |